🛡️ Safety first in #INARMOR research!

As part of WP4 (led by #LEITAT), our team completed the in vivo tolerability assessment and established Maximum Tolerated Dose (#MTD) profiles for our therapeutic candidates.
Crucial groundwork before evaluating efficacy in disease models! 🧵👇

🧪 Led by #LEITAT, with the key collaboration of #UniversityofIceland and WP2 partners, the team assessed key ADME-related properties, Caco-2 permeability and potential mechanisms of action.

🚀 Another step towards preclinical validation and innovative approaches to tackle #AMR.